167 related articles for article (PubMed ID: 36821454)
1. Histological evaluation in biliary diseases.
Saffioti F; Vieira Motta R; Quaglia A
Curr Opin Gastroenterol; 2023 Mar; 39(2):75-82. PubMed ID: 36821454
[TBL] [Abstract][Full Text] [Related]
2. [Gastrointestinal endoscopy in the diagnosis and treatment of biliary liver disease].
Liang XY; Ding HG
Zhonghua Gan Zang Bing Za Zhi; 2022 Jul; 30(7):690-695. PubMed ID: 36038336
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in the Management of Primary Sclerosing Cholangitis.
Assis DN; Bowlus CL
Clin Gastroenterol Hepatol; 2023 Jul; 21(8):2065-2075. PubMed ID: 37084929
[TBL] [Abstract][Full Text] [Related]
4. TLR4, TLR9, and NLRP3 in biliary epithelial cells of primary sclerosing cholangitis: relationship with clinical characteristics.
Matsushita H; Miyake Y; Takaki A; Yasunaka T; Koike K; Ikeda F; Shiraha H; Nouso K; Yamamoto K
J Gastroenterol Hepatol; 2015 Mar; 30(3):600-8. PubMed ID: 25160604
[TBL] [Abstract][Full Text] [Related]
5. [Excerpt from the 2022 American Association for the Study of Liver Diseases clinical practice guideline: management of primary sclerosing cholangitis and cholangiocarcinoma].
Yuan J; Han GH
Zhonghua Gan Zang Bing Za Zhi; 2023 Jan; 31(1):35-41. PubMed ID: 36948847
[TBL] [Abstract][Full Text] [Related]
6. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis.
Reich M; Spomer L; Klindt C; Fuchs K; Stindt J; Deutschmann K; Höhne J; Liaskou E; Hov JR; Karlsen TH; Beuers U; Verheij J; Ferreira-Gonzalez S; Hirschfield G; Forbes SJ; Schramm C; Esposito I; Nierhoff D; Fickert P; Fuchs CD; Trauner M; García-Beccaria M; Gabernet G; Nahnsen S; Mallm JP; Vogel M; Schoonjans K; Lautwein T; Köhrer K; Häussinger D; Luedde T; Heikenwalder M; Keitel V
J Hepatol; 2021 Sep; 75(3):634-646. PubMed ID: 33872692
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management.
Eaton JE; Talwalkar JA; Lazaridis KN; Gores GJ; Lindor KD
Gastroenterology; 2013 Sep; 145(3):521-36. PubMed ID: 23827861
[TBL] [Abstract][Full Text] [Related]
9. Carriers of ABCB4 gene variants show a mild clinical course, but impaired quality of life and limited risk for cholangiocarcinoma.
de Vries E; Mazzetti M; Takkenberg B; Mostafavi N; Bikker H; Marzioni M; de Veer R; van der Meer A; Doukas M; Verheij J; Beuers U
Liver Int; 2020 Dec; 40(12):3042-3050. PubMed ID: 32893960
[TBL] [Abstract][Full Text] [Related]
10. Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group.
Venkatesh SK; Welle CL; Miller FH; Jhaveri K; Ringe KI; Eaton JE; Bungay H; Arrivé L; Ba-Ssalamah A; Grigoriadis A; Schramm C; Fulcher AS;
Eur Radiol; 2022 Feb; 32(2):923-937. PubMed ID: 34363134
[TBL] [Abstract][Full Text] [Related]
11. Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinoma.
Oh HC; Kim MH; Lee KT; Lee JK; Moon SH; Song TJ; Eum J; Park DH; Lee SS; Seo DW; Lee SK
J Gastroenterol Hepatol; 2010 Dec; 25(12):1831-7. PubMed ID: 21091993
[TBL] [Abstract][Full Text] [Related]
12. Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases.
Trauner M; Fickert P; Halilbasic E; Moustafa T
Wien Med Wochenschr; 2008; 158(19-20):542-8. PubMed ID: 18998069
[TBL] [Abstract][Full Text] [Related]
13. Next-generation sequencing in the evaluation of biliary strictures in patients with primary sclerosing cholangitis.
Scheid JF; Rosenbaum MW; Przybyszewski EM; Krishnan K; Forcione DG; Iafrate AJ; Staller KD; Misdraji J; Lennerz JK; Pitman MB; Pratt DS
Cancer Cytopathol; 2022 Mar; 130(3):215-230. PubMed ID: 34726838
[TBL] [Abstract][Full Text] [Related]
14. Novel histological scoring for predicting disease outcome in primary sclerosing cholangitis.
Sjöblom N; Boyd S; Kautiainen H; Arola J; Färkkilä M
Histopathology; 2022 Aug; 81(2):192-204. PubMed ID: 35510514
[TBL] [Abstract][Full Text] [Related]
15. Biliary dysplasia, cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma.
Bergquist A; Glaumann H; Stål P; Wang GS; Broomé U
J Intern Med; 2001 Jan; 249(1):69-75. PubMed ID: 11168786
[TBL] [Abstract][Full Text] [Related]
16. Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma.
Boyd S; Mustonen H; Tenca A; Jokelainen K; Arola J; Färkkilä MA
Scand J Gastroenterol; 2017 Feb; 52(2):242-249. PubMed ID: 27806633
[TBL] [Abstract][Full Text] [Related]
17. Primary sclerosing cholangitis as a cause of false positive bile duct brushing cytology: report of two cases.
Layfield LJ; Cramer H
Diagn Cytopathol; 2005 Feb; 32(2):119-24. PubMed ID: 15637668
[TBL] [Abstract][Full Text] [Related]
18. Primary sclerosing cholangitis and cholangiocarcinoma.
Lazaridis KN; Gores GJ
Semin Liver Dis; 2006 Feb; 26(1):42-51. PubMed ID: 16496232
[TBL] [Abstract][Full Text] [Related]
19. Management of primary sclerosing cholangitis.
Björnsson E
Minerva Gastroenterol Dietol; 2009 Jun; 55(2):163-72. PubMed ID: 19305376
[TBL] [Abstract][Full Text] [Related]
20. Sclerosing cholangitis may mimic radiological pattern of cholangiocarcinoma: Differential diagnosis and review of literature.
Isaia I; Natoli G; Colaci M; Stancanelli B; Malatino L
Am J Med Sci; 2022 Sep; 364(3):359-365. PubMed ID: 35469769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
